MIRA INFORM REPORT

 

 

Report Date :

22.08.2014

 

IDENTIFICATION DETAILS

 

Name :

LABORATORIO CHILE S.A.

 

 

Registered Office :

Marathon 1315 Nuñoa, Santiago, XIII Regiòn Metropolitana

 

 

Country :

Chile

 

 

Date of Incorporation :

2001

 

 

Legal Form :

Joint-Stock Company

 

 

Line of Business :

Subject is engaged in manufacture and sale of pharmaceutical and veterinary products.

 

 

No of Employees :

1,100

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 01, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Chile

A2

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderate Low Risk

 

B1

Moderate Risk

 

B2

Moderate High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


CHILE - ECONOMIC OVERVIEW

 

Chile has a market-oriented economy characterized by a high level of foreign trade and a reputation for strong financial institutions and sound policy that have given it the strongest sovereign bond rating in South America. Exports of goods and services account for approximately one-third of GDP, with commodities making up some three-quarters of total exports. Copper alone provides 19% of government revenue. From 2003 through 2013, real growth averaged almost 5% per year, despite the slight contraction in 2009 that resulted from the global financial crisis. Chile deepened its longstanding commitment to trade liberalization with the signing of a free trade agreement with the US, which took effect on 1 January 2004. Chile has 22 trade agreements covering 60 countries including agreements with the European Union, Mercosur, China, India, South Korea, and Mexico. Chile has joined the United States and nine other countries in negotiating the Trans-Pacific-Partnership trade agreement. The Chilean Government has generally followed a countercyclical fiscal policy, accumulating surpluses in sovereign wealth funds during periods of high copper prices and economic growth, and generally allowing deficit spending only during periods of low copper prices and growth. As of 31 December 2012, those sovereign wealth funds - kept mostly outside the country and separate from Central Bank reserves - amounted to more than $20.9 billion. Chile used these funds to finance fiscal stimulus packages during the 2009 economic downturn. In May 2010 Chile signed the OECD Convention, becoming the first South American country to join the OECD.

 

Source : CIA

 


IDENTIFICATION

 

CORRECT COMPANY NAME

LABORATORIO CHILE S.A.

TAXPAYER REGISTRATION

RUT 775969407

MAIN ADDRESS

Marathon 1315 Nuñoa, Santiago

DEPT/PROV/REGION/STATE

XIII Regiòn Metropolitana

COUNTRY

CHILE

TELEPHONE

(562) 23655014 23655000 23655235

CORPORATE E-MAIL

elleny.nazar@laboratoriochile.cl

WEB

www.labchile.com

COMMENTS

 

We further recall that the order was forwarded without phone number to expedite the investigation.

 

EXECUTIVE SUMMARY

 

Date of foundation

2001

Capital stock

Ps$217,743,519,889.= Pesos

permanent employees

1,100

Chief Executive

PFEIFFER FRENZ, HERNAN

Disposition

SATISFACTORY

Payments policy

Usually to terms / good

Credit (**)

Risk is Minimal, Solvent, Satisfactory Financial Situation.

Number of times that this company was required: 10

 

LEGAL STRUCTURE

 

LEGAL STATUS

Joint-Stock Company

 

 

DATE OF INCORPORATION

2001

 

 

PLACE OF REGISTRY

Santiago

 

 

NOTARY OFFICE

 

DURATION

Perpetual

REGISTRATION

No.10.303, Page 12804 of Trade Registry - Santiago

 

 

CURRENT PAID-IN CAPITAL

Ps$217,743,519,889.= Pesos

LAST CAPITAL INCREASE

28/09/2004

CURRENT EXCHANGE RATE (US$)

Ps$575,99 per 1USD

 

 

COMMENTS

 

The last capital increase was carried out on September 28, 2004 due to a merger.
 
The company's capital is divided in 315,963,033 single series, registered shares.

 

DIRECTORS - EXECUTIVES – SHAREHOLDERS

 

FULL NAMES / COMPANY NAME

TITLE

%PART.

SINCE

PFEIFFER FRENZ, HERNAN

General Manager

 

 

HENRIQUEZ, NORMAN

Admin. & Finance Manager

 

 

CHAVEZ, VLADIMIR

Operations Manager

 

 

HEREDIA P., EDUARDO

Sales Manager

 

 

GARCIA A., CLAUDIO

Marketing Manager

 

 

RUIZ, PATRICIO

Human Resources Manager

 

 

GARSTMAN, JAIME

Finance Manager

 

 

BASTIAS ALVAREZ, HECTOR

General Accountant

 

 

IVAX HOLDING C.I.

Shareholder / Member

99.99%

 

 

 

 

 

WHO IS WHO?

 

PFEIFFER FRENZ, HERNAN

TITLE

General Manager

NATIONALITY

Chilean

PROFESSION

Commercial Engineer

BACKGROUND INFORMATION

He graduated from Universidad Adolfo Ibañez (1977-1981 ). 
He studied a Senior Management Program at Universidad de Los Andes (2004 ).

 

 

 

 

IVAX HOLDING C.I.

 

 

BUSINESS BACKGROUND

Cayman Islands-based company

 

BUSINESS HISTORY

 

Subject Company was incorporated in 2001 as INVERSIONES GLACIAR I LTDA. Then, its legal status was changed to a Joint Stock Company, adopting the company name GLACIAR S.A..
 
By Public Deed, dated 29/05/2001, before Rene Benavente Cash, Notary from Santiago, published in the Official Gazette on 12/06/2001, page No.20, the company's partners were changed.  Mr. Jose Maria Eyzaguirre Baeza transferred all his rights (99.99) to Ivax Holdings C.I., and  Mr. Matias Mackenna Vicuña transferred his rights (0.1%) to Ivax Corporation, and the assignors withdrew.
 
By Public Deed dated 02/0//2004, before Pablo Roberto Poblete S., Notary from Santiago, published in the Official Gazette on 10/08/2004, page No.32, the company's corporate name was changed from GLACIAR S.A. to LABORATORIO CHILE S.A.
 
By Public Deed dated 28/09/2004, before Rene Benavente Cash, Notary from Santiago, published in the Official Gazette on 06/10/2004, page No.17, the company's bylaws were changed.  The merger between LABORATORIO CHILE S.A. (RUT 77.596.940-7) and its subsidiary, LABORATORIO CHILE S.A. (RUT 90.322.000-7) was authorized. The latter company was dissolved.
 
It is known that TEVA GROUP (Israel) has been the owner of LABORATORIO CHILE S.A. since July 2006. IVAX merged with TEVA. The owner of IVAX HOLDING (it was established as an investment company to acquire the laboratory) TEVA. IVAX CORPORATION (USA) Some companies in the group are still called IVAX, others not anymore. In Peru, the company is called CORPORACION MEDCO, in Uruguay ELVEDIUM, in Colombia LBC, in Mexico LEMERI or IVAX MEXICO.

 

 

RELATED COMPANIES TO SUBJECT COMPANY OR TO MAJORITY SHAREHOLDER

 

COMPANY NAME

COUNTRY

TAX REG.

RELATION %

ELVEDIUM

URUGUAY

 

Related

IVAX ARGENTINA S.A.

ARGENTINA

 

Related

IVAX CORPORATION

U.S.A.

 

Related

LBC

COLOMBIA

 

Related

TEVA PERU S.A.

PERU

(AC) 20101269834

Related

 

 

BUSINESS

 

SIC Classification

T - PROD. QUIMICOS- PLASTICOS- VETERINARIOS-AGROQUIMICOS (Industria quimica en general, Produccion y comercializacion de plasticos y derivados, Veterinarios y agroquímicos, Reactivos)

Main activity

Subject is engaged in manufacture and sale of pharmaceutical and veterinary products.

OPERATIONS

Import

Yes

Country

Uruguay, Argentina, China, India, Switzerland, Spain, Colombia, Holland, Israel

ANNUAL Imports In US$ (CIF)

YEAR

AMOUNT

2014

2,669,887.83

2013

40,918,851.78

2012

45,002,860.95

2011

40,931,201.53

2010

37,616,614.32

2009

32,232,423.81

Export

Yes

COUNTRY

Bolivia, Paraguay, Venezuela, Ecuador, Uruguay, El Salvador, Mexico, Switzerland

Annual exports in US$ (FOB)

YEAR

AMOUNT

2014

530,890.52

2013

21,326,560.55

2012

23,882,766.29

2011

24,647,886.16

2010

15,185,216.76

2009

15,419,616.31

% Credit SALES / Terms

100% (60-day terms)

% DOMESTIC PURCHASES

40%

% FOREIGN PURCHASES

60%

SELLING TerritorY

Domestic and international market

EMPLOYEES

1,100

LOCATION

PREMISES

Own Settled

OTHER PREMISES

The Tax domicile and Offices operate at the main address.
 
Subject has two Production Plants.

Comments

 

Subject's client portfolio includes drugstores, supermarket chains, hospitals, clinics, municipalities and veterinary centers, such as:
- Farmacias Ahumada S.A.
- Salcobrand SA
- Farmacias Cruz Verde S.A.
 
Subject manufactures and distributes a diversified portfolio of 600 pharmaceutical products, including 90 clinical and specialized presentations for hospital use.
 
Currently, it has two production plants with an annual production capacity of 3,300 million industrial units and flexible manufacturing processes, having one of the lowest cost of production per unit in Latin America.

 

 

FINANCIAL INFORMATION

 

Disposition

Poor. Very few information was given. Politely.

Interviewee(s)

Hector Bastias

Position(s)

General Accountant

Information provided

The interviewee only confirmed operating information.

 

 

SALES

US$ 0.00 ()

FINANCIAL SITUATION

SATISFACTORY
Although there are no Financial Statements available, reportedly the company has the economic support of the owners. It is publicly known that it operates without further problems.

Property of company comments

 

Subject's main assets include:
- Industrial machinery and equipment
- Office furniture 
- Computer equipment
 

INSURANCE

COMPANY

AGAINST

SEGUROS M & T BENTFIELD

All risk

 

 

TRADE REFERENCES, CREDIT BUREAU, LAWSUITS, BANKS

 

(Confidential Information)

TRADE REFERENCES

Supplier: LABORATORIOS BOSTON S.A.

Tel.: (56.2) 4458500

Country: CHILE

Goods/Services? : Manufacture of medical products

 

 

Highest credit? : DC Open

 

Current

Client since? : 1999

Terms? : 60 days

Performance? : Prompt

Comments : Monthly average: 50-60 million Pesos. Good client.

Supplier: FARET SA

Tel.: (56.2) 4135000

Country: CHILE

Goods/Services? : Card boxes

 

 

Highest credit? : DC Open

 

Current

Client since? : 1994

Terms? : 60 days

Performance? : Prompt

Comments : Monthly average: 10 millions. Good client.

Supplier: CRISTALERIAS TORO SAIC

Tel.: 562 2 2437 4500

Country: CHILE

Goods/Services? : Glass containers

 

 

Highest credit? : DC Open

 

Current

Client since? : 1994

Terms? : 75 days

Performance? : Prompt

Comments : Monthly average: 5 million Pesos. Good client.

Supplier: LABORATORIOS LASCA

Tel.: (595 21) 506 889

Country: PARAGUAY

Goods/Services? : Chemical inputs

 

 

Highest credit? : DC 300,000,000.=

 

Current

Client since? : 2011

Terms? : 90 days

Performance? : Prompt

Comments : Good client

Supplier: ETAL IMPRENTA LTDA.

Tel.: (56.2) 2384863

Country: CHILE

Goods/Services? : Printing service

 

 

Highest credit? : DC 20,000,000.=

 

Current

Client since? : 2003

Terms? : 60 days

Performance? : Prompt

Comments : Good client.

 

Note : Other suppliers did not provide information or could not be consulted

 

Supplier

Country

CRISTALERIAS DE CHILE SA

CHILE

AGENCIA REPRESENTACIONES LTDA.

CHILE

PROCATS

COLOMBIA

OFIMARKET

CHILE

CHEMO

SWITZERLAND

 

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.77

UK Pound

1

Rs.100.72

Euro

1

Rs.80.56

 

 

INFORMATION DETAILS

 

Analysis Done by :

SUB

 

 

Report Prepared by :

SMN

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

--

NB

                                       New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.